BP, OMV Seal LNG Supply Agreement
By Mauro Orru
British oil-and-gas major BP signed a long-term sale and purchase agreement with Austria's OMV for the supply of liquefied natural gas.
The Austrian oil-and-gas company said Friday that the 10-year agreement covers the supply of up to 1 million metric tons of liquefied natural gas a year starting in 2026.
BP will supply the gas, which will be regasified in the Netherlands, where OMV has regasification capacity, or other terminals in Europe.
Meanwhile, OMV unveiled what it called the largest natural gas discovery in Austria in 40 years at the Wittau Tief-2a exploration well.
The group said a preliminary assessment indicates potential recoverable resources of roughly 48 terawatt hours, or 28 million barrels of oil equivalent. OMV expects its natural gas production in Austria to increase by 50% after full development of the site.
OMV didn't disclose financial terms of the deal.
Write to Mauro Orru at mauro.orru@wsj.com; @MauroOrru94
(END) Dow Jones Newswires
July 28, 2023 02:49 ET (06:49 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track